share_log

华森制药(002907.SZ)两款产品拟中选第十批全国药品集中采购

Chongqing Pharscin Pharmaceutical (002907.SZ) plans to have two products selected in the tenth round of national pharmaceutical centralized procurement.

Zhitong Finance ·  04:34

Chongqing Pharscin Pharmaceutical (002907.SZ) announced that on December 12, 2024, the company participated in the national organized...

According to Zhithong Finance APP, Chongqing Pharscin Pharmaceutical (002907.SZ) announced that on December 12, 2024, the company participated in the tenth batch of national centralized procurement work organized by the National Organization for Pharmaceutical Joint Procurement Office ("Joint Procurement Office"). According to the "Proposed Selection Results Table for National Drug Centralized Procurement" (GYYD2024-2) released by the Joint Procurement Office, the company's products, Compound Polyethylene Glycol Electrolyte Powder (III) and Mesylate Resagiline Tablets, are proposed to be selected for this centralized procurement.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment